Concord Common Stock Total Equity from 2010 to 2024

CCM Stock  USD 0.69  0.28  28.87%   
Concord Medical Common Stock Total Equity yearly trend continues to be very stable with very little volatility. Common Stock Total Equity is likely to drop to about 111.2 K. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2008-12-31
Previous Quarter
105 K
Current Value
105 K
Quarterly Volatility
29.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Concord Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concord Medical's main balance sheet or income statement drivers, such as Interest Expense of 174 M, Selling General Administrative of 186.8 M or Total Revenue of 441 M, as well as many indicators such as Price To Sales Ratio of 0.6, Dividend Yield of 0.14 or Days Sales Outstanding of 47.42. Concord financial statements analysis is a perfect complement when working with Concord Medical Valuation or Volatility modules.
  
Check out the analysis of Concord Medical Correlation against competitors.

Latest Concord Medical's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Concord Medical Services over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Concord Medical's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Concord Medical's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Concord Common Stock Total Equity Regression Statistics

Arithmetic Mean103,129
Geometric Mean101,900
Coefficient Of Variation13.55
Mean Deviation6,417
Median105,000
Standard Deviation13,974
Sample Variance195.3M
Range65.8K
R-Value0.56
Mean Square Error144.9M
R-Squared0.31
Significance0.03
Slope1,742
Total Sum of Squares2.7B

Concord Common Stock Total Equity History

2024111.2 K
2023120.8 K
2011105 K
201055 K

About Concord Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Concord Medical income statement, its balance sheet, and the statement of cash flows. Concord Medical investors use historical funamental indicators, such as Concord Medical's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Concord Medical investors may use each financial statement separately, they are all related. The changes in Concord Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Concord Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Concord Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Concord Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity120.8 K111.2 K

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Concord Medical Services using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in Concord Stock

When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out the analysis of Concord Medical Correlation against competitors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.96)
Revenue Per Share
12.302
Quarterly Revenue Growth
(0.23)
Return On Assets
(0.05)
Return On Equity
(0.28)
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.